Since MIR200CHG is more highly expressed in luminal A breast cancer and YB-1 is more highly expressed in triple-negative breast cancer, we believe that the endogenous expression of YB-1 in breast cancer is regulated by more other factors. Here, MIR200CHG is linked to breast carcinoma.